Literature DB >> 17000727

Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice.

Katrin Breitbach1, Sonja Klocke, Thomas Tschernig, Nico van Rooijen, Ulrich Baumann, Ivo Steinmetz.   

Abstract

Infection with the soil bacterium Burkholderia pseudomallei can result in a variety of clinical outcomes, including asymptomatic infection. The initial immune defense mechanisms which might contribute to the various outcomes after environmental contact with B. pseudomallei are largely unknown. We have previously shown that relatively resistant C57BL/6 mice can restrict bacterial B. pseudomallei growth more efficiently within 1 day after infection than highly susceptible BALB/c mice. By using this model, our study aimed to investigate the role of macrophage-mediated effector mechanisms during early B. pseudomallei infection. Depletion of macrophages revealed an essential role of these cells in the early control of infection in BALB/c and C57BL/6 mice. Strikingly, the comparison of the anti-B. pseudomallei activity of bone marrow-derived macrophages (BMM) from C57BL/6 and BALB/c mice revealed an enhanced bactericidal activity of C57BL/6 BMM, particularly after gamma interferon (IFN-gamma) stimulation. In vitro experiments with C57BL/6 gp91phox-/- BMM showed an impaired intracellular killing of B. pseudomallei compared to experiments with wild-type cells, although C57BL/6 gp91phox-/- cells still exhibited substantial killing activity. The anti-B. pseudomallei activity of C57BL/6 iNOS-/- BMM was not impaired. C57BL/6 gp91phox-/- mice lacking a functional NADPH oxidase were more susceptible to infection, whereas C57BL/6 mice lacking inducible nitric oxide synthase (iNOS) did not show increased susceptibility but were slightly more resistant during the early phase of infection. Thus, our data suggest that IFN-gamma-mediated but iNOS-independent anti-B. pseudomallei mechanisms of macrophages might contribute to the enhanced resistance of C57BL/6 mice compared to that of BALB/c mice in the early phase of infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000727      PMCID: PMC1695503          DOI: 10.1128/IAI.00966-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  The quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease.

Authors:  Jin Huang; Fred J DeGraves; Stephen D Lenz; Dongya Gao; Pu Feng; Dan Li; Tobias Schlapp; Bernhard Kaltenboeck
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen.

Authors:  Mark P Stevens; Michael W Wood; Lowrie A Taylor; Paul Monaghan; Pippa Hawes; Philip W Jones; Timothy S Wallis; Edouard E Galyov
Journal:  Mol Microbiol       Date:  2002-11       Impact factor: 3.501

Review 3.  Melioidosis.

Authors:  David A B Dance
Journal:  Curr Opin Infect Dis       Date:  2002-04       Impact factor: 4.915

Review 4.  Nitric oxide and superoxide in inflammation and immune regulation.

Authors:  T J Guzik; R Korbut; T Adamek-Guzik
Journal:  J Physiol Pharmacol       Date:  2003-12       Impact factor: 3.011

5.  Actin-based motility of Burkholderia pseudomallei involves the Arp 2/3 complex, but not N-WASP and Ena/VASP proteins.

Authors:  Katrin Breitbach; Klemens Rottner; Sonja Klocke; Manfred Rohde; Andrea Jenzora; Jürgen Wehland; Ivo Steinmetz
Journal:  Cell Microbiol       Date:  2003-06       Impact factor: 3.715

6.  Phagocyte NADPH oxidase, but not inducible nitric oxide synthase, is essential for early control of Burkholderia cepacia and chromobacterium violaceum infection in mice.

Authors:  Brahm H Segal; Li Ding; Steven M Holland
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

7.  Biodefense-driven murine model of pneumonic melioidosis.

Authors:  J A Jeddeloh; D L Fritz; D M Waag; J M Hartings; G P Andrews
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

Review 8.  Melioidosis.

Authors:  N J White
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

9.  Genetic control of natural resistance of mouse macrophages to Coxiella burnetii infection in vitro: macrophages from restrictive strains control parasitophorous vacuole maturation.

Authors:  Dario S Zamboni
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Intensity of rainfall and severity of melioidosis, Australia.

Authors:  Bart J Currie; Susan P Jacups
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

View more
  53 in total

1.  Fate of a Burkholderia pseudomallei lipopolysaccharide mutant in the mouse macrophage cell line RAW 264.7: possible role for the O-antigenic polysaccharide moiety of lipopolysaccharide in internalization and intracellular survival.

Authors:  S Arjcharoen; C Wikraiphat; M Pudla; K Limposuwan; D E Woods; S Sirisinha; P Utaisincharoen
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

2.  Cationic liposomes extend the immunostimulatory effect of CpG oligodeoxynucleotide against Burkholderia pseudomallei infection in BALB/c mice.

Authors:  Apichaya Puangpetch; Robert Anderson; Yan Y Huang; Rasana W Sermswan; Wanpen Chaicumpa; Stitaya Sirisinha; Surasakdi Wongratanacheewin
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

3.  Low-dose exposure of C57BL/6 mice to burkholderia pseudomallei mimics chronic human melioidosis.

Authors:  Laura Conejero; Natasha Patel; Melanie de Reynal; Sara Oberdorf; Joanne Prior; Philip L Felgner; Richard W Titball; Francisco J Salguero; Gregory J Bancroft
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

4.  Protection from pneumonic infection with burkholderia species by inhalational immunotherapy.

Authors:  Andrew Goodyear; Lisa Kellihan; Helle Bielefeldt-Ohmann; Ryan Troyer; Katie Propst; Steven Dow
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

5.  Caspase-1 mediates resistance in murine melioidosis.

Authors:  Katrin Breitbach; Guang Wen Sun; Jens Köhler; Kristin Eske; Patimaporn Wongprompitak; Gladys Tan; Yichun Liu; Yunn-Hwen Gan; Ivo Steinmetz
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

6.  Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 in lipopolysaccharide-stimulated RAW264.7 cells by carboxybutyrylated glucosamine takes place via down-regulation of mitogen-activated protein kinase-mediated nuclear factor-kappaB signaling.

Authors:  Niranjan Rajapakse; Moon-Moo Kim; Eresha Mendis; Se-Kwon Kim
Journal:  Immunology       Date:  2008-01-18       Impact factor: 7.397

Review 7.  Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Sara K Bondi; Joanna B Goldberg
Journal:  Expert Rev Vaccines       Date:  2008-11       Impact factor: 5.217

8.  Osteopontin impairs host defense during established gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis).

Authors:  Gerritje J W van der Windt; W Joost Wiersinga; Catharina W Wieland; Ivo C S I Tjia; Nicholas P Day; Sharon J Peacock; Sandrine Florquin; Tom van der Poll
Journal:  PLoS Negl Trop Dis       Date:  2010-08-31

9.  Detrimental role of CC chemokine receptor 4 in murine polymicrobial sepsis.

Authors:  Tobias Traeger; Wolfram Kessler; Volker Assfalg; Katharina Cziupka; Pia Koerner; Constanze Dassow; Katrin Breitbach; Marlene Mikulcak; Ivo Steinmetz; Klaus Pfeffer; Claus-Dieter Heidecke; Stefan Maier
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

10.  Innate immune responses of pulmonary epithelial cells to Burkholderia pseudomallei infection.

Authors:  Siew Hoon Sim; Yichun Liu; Dongling Wang; Vidhya Novem; Suppiah Paramalingam Sivalingam; Tuck Weng Thong; Eng Eong Ooi; Gladys Tan
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.